Babraham Institute Adopts DNASTAR Lasergene Software
October 3, 2013
MADISON, Wisconsin –– DNASTAR today announced that the Babraham Institute has chosen DNASTAR Lasergene software as its primary sequence assembly and analysis software platform for researchers within its organization. A spokesperson for the Babraham Institute said, “Many of our scientists have used Lasergene sequence analysis software for several years and been extremely satisfied with it. [...]
Air Products Applauds Approval of Helium Legislation
October 3, 2013
Lehigh Valley, Pa. -- Air Products (NYSE:APD) today applauded President Barack Obama and members of both the United States Senate and House of Representatives for their work in successfully passing vital legislation needed for the continuation of the critical helium supply from the U.S. Bureau of Land Management (BLM) Federal Helium Reserve. The BLM reserve [...]
Lawsuit against Enzymatics and three former NEB® employees
October 2, 2013
Ipswich, MA – New England Biolabs, Inc. (NEB®), which filed suit against Enzymatics and three former NEB employees for stealing its intellectual property, intends to appeal today’s decision by the Massachusetts Superior Court after the court declined to rule on the merits of the case, because of a technicality about the timing of when the [...]
Cellular Dynamics Issued U.S. Patent Covering iPSC Episomal Reprogramming
October 2, 2013
MADISON, Wis. -- Cellular Dynamics International (CDI) (Nasdaq:ICEL), announced today that the U.S. Patent and Trademark Office (PTO) issued Patent No. 8,546,140 entitled "Methods for the Production of iPS Cells Using Non-Viral Approach" on October 1. The newly issued patent relates to the method by which adult tissue cells, such as blood or skin, are [...]
October 2, 2013
Billerica, Mass. —— Aushon BioSystems, a provider of multiplex immunoassay products and services, and Pacific Biomarkers, a leading provider of clinical biomarker laboratory services, have announced today that Pacific Biomarkers has adopted the Cira platform for multiplex biomarker analysis. Pacific Biomarkers will provide enhanced clinical laboratory services, including protocol consultation, sample testing, project management, data [...]
Navios Flow Cytometer Cleared for Diagnostic Use in U.S. and China
October 2, 2013
INDIANAPOLIS –– Beckman Coulter Life Sciences has received 510(k) clearance from the U.S. Food and Drug Administration and an Import Medical Device Registration Certificate from the China Food and Drug Administration for the in vitro diagnostic use of the Navios flow cytometry system. In the U.S., the Navios flow cytometer is intended for immunophenotyping in [...]
BioNano Genomics Raises $10 Million Financing To Advance Irys System For Human Genome Analysis
October 2, 2013
SAN DIEGO -- BioNano Genomics announced today a $10 million financing to support the ongoing development and commercialization of the IrysTM System for human genome analysis. Current investors, Battelle Ventures, Domain Associates, Gund Investment Corporation, participated in the financing. "BioNano Genomics has made significant progress in commercializing the Irys System first in the U.S. and [...]
Spectro Inc. Acquires Wilks Enterprise, Inc.
October 2, 2013
CHELMSFORD, Mass. -- Spectro Inc., a leading Chelmsford, Mass.-based developer and manufacturer of analytical tools and software for the industrial performance fluids market, today announced it has purchased Wilks Enterprise, Inc. for an undisclosed sum. Wilks, based in Norwalk, Conn. and established in 1995, specializes in the development and manufacture of mid-infrared (mid-IR) application specific [...]
October 2, 2013
Valencia, Spain and Aarhus, Denmark -- Today CLC bio and BioBam Bioinformatics announced an integrated workflow for researchers working with non-model organisms without reference sequences. By combining the Blast2GO PRO plugin and CLC Genomics Workbench, this workflow allows users to combine and integrate NGS bioinformatics data analyses on one platform, covering the whole data analysis [...]
Sequenom Files Premarket 510(k) Notification With FDA For IMPACT Dx™ System
October 2, 2013
SAN DIEGO -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced that it has submitted Premarket 510(k) Notifications to the United States Food and Drug Administration (FDA) for its IMPACT Dx™ System and its IMPACT Dx™ Factor V Leiden and Factor II Genotyping Test. The [...]
